| Why is intra-abdominal pressure (IAP) monitoring important? |
| Abnormal intra-abdominal pressure (IAP) is associated with critical conditions such as shock, renal failure, and respiratory distress. Current measurement methods often rely on invasive catheters or bladder pressure, which are time-consuming and infection-prone. PressureDOT offers a noninvasive, continuous, and long-duration alternative that improves diagnostic accuracy and patient safety. |
| What clinical studies are currently underway at Dotspace? |
| Dotspace has completed a 10-patient clinical pilot study and an additional 20 non-medical use trials involving athletes to assess the feasibility of pressure monitoring under physical load. The company is now preparing for a pivotal clinical study for FDA 510(k) submission, which will be conducted as a multi-site trial in both the U.S. and Taiwan. Hospitals or research centers interested in collaboration are welcome to reach out. |
| What has been the main clinical feedback on PressureDOT? |
| Clinicians and research teams have noted that PressureDOT outperforms conventional methods in terms of ease of use, patient comfort, and data continuity. Its wireless design enables more efficient patient monitoring and clinical decision-making. |
